Clinical Trial: Effect of CBD-Based Vaginal Suppositories on Menopausal Symptoms

U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06804889) titled 'Effect of CBD-Based Vaginal Suppositories on Menopausal Symptoms' on Jan. 20.

Brief Summary: Efficacy and safety of the medical device CANNEFF(R) vaginal suppositories containing two active ingredients cannabidiol (CBD) and hyaluronic acid (HA) in alleviating menopausal symptoms and improving quality of life in (post)menopausal women will be evaluated.

Study Start Date: March 01, 2023

Study Type: INTERVENTIONAL

Condition: Menopause and Genitourinary Syndrome

Intervention: DEVICE: CANNEFF(R) VAG SUP vaginal suppositories

CANNEFF(R) VAG SUP vaginal suppositories containing 100 mg cannabidiol - CBD and 6.6 mg hyaluronic acid - HA...